Accuracy of Non-invasive Hemoglobin Monitoring in Patients Undergoing Outpatient Total Joint Arthroplasty
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Total Joint Arthroplasty
- Sponsor
- Mayo Clinic
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Concordance between non-invasive Hgb and serum Hgb
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.
Investigators
Matthew P. Abdel, M.D.
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Adult patients age ≥
- •Undergoing either primary total knee or total hip arthroplasty for a primary underlying diagnosis of osteoarthritis.
Exclusion Criteria
- •Individuals \< 18 years of age.
Outcomes
Primary Outcomes
Concordance between non-invasive Hgb and serum Hgb
Time Frame: 1 hour
How closely the non-invasive and serum Hgbs correlate with one another statistically
Patient satisfaction with non-invasive Hgb
Time Frame: 1 day
Patients will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method
Nurse satisfaction with non-invasive Hgb
Time Frame: 1 day
Nurses will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method
Cost comparison between non-invasive and serum Hgb
Time Frame: 1 year
We will analyze cost differences between the non-invasive Hgb devices and the serum lab tests